The art of bone regeneration
Leader Biomedical’s OssGro® line is produced with MBCP™ Technology, a method producing biphasic bone substitutes closely resembling natural bone, for optimal bone regeneration. Unlike other bulk production methodologies, this method relies on a controlled process of synthesis, sublimation, and sintering.
Regeneration
- The specific combination of 60% HA and 40% βTCP results in a highly regulated resorption rate
- Release of Ca2+ and PO43- ions promote controlled bone regeneration
Porosity
- Macroporous structure proven ideal for cell colonisation and improved osteoconductivity
- Microporous structure ensures interstitial fluids flow freely to enable growth factors to reach cells
Permeability
- The fully permeable network of interconnected pores absorbs three times the graft’s weight in fluids, like bone marrow, in under two minutes
Safety
- No risk of residual chemical or organic material
Availability
- No natural limit on availability